Article by Hannah Crowe, editor of The Impact Review
Read this article, authored by Hannah Crowe and published by the Impact Review. It discusses how our founder, Alok Tayi’s personal experience with rare disease drove him towards a mission – to fund cures for rare diseases. Out of this mission, Vibe Bio was born.
“In pursuit of a solution, Alok founded a company called Vibe Bio that enables funding for high potential drug programmes, especially in rare diseases. Through a community of patients, scientists, and partners, Vibe Bio’s goal is to identify the most promising candidates for a disease and ensure they receive enough funding to surpass their inflection points.”
